- ICH GCP
- US-Register für klinische Studien
- Forscher
- Griechenland
- Kopf-Hals-Neubildungen
Medizinische Spezialisten aus Griechenland, markiert als Forscher in klinischen Studien, die Kopf-Hals-Neubildungen untersuchen
Insgesamt 9 ergebnisse
-
Amanda PsyrriGesehen in:
- Athens, GSK Investigational Site
- Athens, University General Hospital "ATTIKON"
- Attikí, Chaidari, Attikon General University Hospital
- Haidari, Athens, GSK Investigational Site
Versuche:- NCT05386550 (Hauptermittler)
- NCT05514054 (Hauptermittler)
- NCT05565378 (Hauptermittler)
- NCT06062420 (Hauptermittler)
- NCT06256588 (Hauptermittler)
-
Athanasios ArgyrisGesehen in:
- Athens, GSK Investigational Site
Versuche:- NCT06062420 (Hauptermittler)
Bedingungen: -
Athanasios KotsakisGesehen in:
- Larisa, GSK Investigational Site
- Larissa, GSK Investigational Site
- Other, Larissa, University Hospital of Larissa
- Thessalía, Larissa, University General Hospital of Larissa
Versuche:- NCT04975308 (Hauptermittler)
- NCT05514054 (Hauptermittler)
- NCT05132582 (Hauptermittler)
- NCT05565378 (Hauptermittler)
- NCT06256588 (Hauptermittler)
-
Eleni FoutzilaGesehen in:
- Thessaloniki, GSK Investigational Site
Versuche:- NCT06062420 (Hauptermittler)
Bedingungen: -
Eleni LinardouGesehen in:
- Piraeus, Metropolitan Hospital "Perseus Healthcare Group SA" 4th Oncology Department
Versuche:- NCT03504488 (Hauptermittler)
-
Ioannis BoukovinasGesehen in:
- Kentrikí Makedonía, Thessaloniki, Bioclinic Thessaloniki
- Kentrikí Makedonía, Thessaloniki, Bioclinic Thessalonikis Private Clinic Single Member S.A.
- Thessaloniki, Bioclinic Thessaloniki
- Thessaloniki, Bioclinic Thessaloniki, Οncology Department
- Thessaloniki, GSK Investigational Site
Versuche:- NCT05514054 (Hauptermittler)
- NCT04681131 (Hauptermittler)
- NCT03504488 (Hauptermittler)
- NCT06062420 (Hauptermittler)
-
IOANNIS MOUNTZIOSGesehen in:
- Athens, GSK Investigational Site
- Athens, HENRY DUNANT Hospital Center, 4th Department of Medical Oncology and Clinical Trials Unit
- Athens, Henry Dunant Hospital Center
- Attikí, Athens, Errikos Dunant Hospital Center
Versuche:- NCT04475939 (Hauptermittler)
- NCT04819100 (Hauptermittler)
- NCT03504488 (Hauptermittler)
- NCT05372081 (Hauptermittler)
- NCT06119581 (Hauptermittler)
-
Konstantinos SyrigosGesehen in:
- Athens, "Sotiria" Chest Diseases Hospital of Athens, 3rd Department of Internal Medicine of University of Athens, Oncology Unit
- Athens, GSK Investigational Site
- Athens, General Hospital of Athens of Chest Diseases "SOTIRIA" - Sotiria Thoracic Diseases Hospital of Athens
- Attikí, Athens, Sotiria Thoracic Diseases Hospital of Athens
Versuche:- NCT04819100 (Hauptermittler)
- NCT05386550 (Hauptermittler)
- NCT03504488 (Hauptermittler)
- NCT05565378 (Hauptermittler)
- NCT06119581 (Hauptermittler)
-
Sofia BakaGesehen in:
- Asklipiou 10, Thessaloníki, Interbalkan Hospital
- Efkarpia, GSK Investigational Site
- Thessaloniki, European Interbalkan Medical Center
- Thessaloniki, European Interbalkan Medical Center, Οncology Department
- Thessaloniki, GSK Investigational Site
- Thessaloniki, Interbalkan Hospital of Thessaloniki
- Thessaloníki, Thessaloniki, European Interbalkan Medical Center
Versuche:- NCT04975308 (Hauptermittler)
- NCT04819100 (Hauptermittler)
- NCT04211337 (Hauptermittler)
- NCT05386550 (Hauptermittler)
- NCT05514054 (Hauptermittler)
- NCT04681131 (Hauptermittler)
- NCT03504488 (Hauptermittler)
- NCT03390686 (Hauptermittler)
- NCT05565378 (Hauptermittler)
- NCT06119581 (Hauptermittler)
- NCT06256588 (Hauptermittler)
Bedingungen:- Neoplasien der Brust;
- Neoplasma Metastasierung;
- Karzinom, nicht-kleinzellige Lunge;
- Medullärer Schilddrüsenkrebs;
- Kopf-Hals-Krebs;
- Nicht-kleinzelligem Lungenkrebs;
- Melanom;
- Nicht-kleinzelligem Lungenkrebs;
- Dreifach negativer Brustkrebs;
- Lungenkrebs;
- Nicht-kleinzelligem Lungenkrebs;
- Lungenkrebs, nicht-kleinzellig;
- Neubildungen, Kopf und Hals